Standout Papers

Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6):... 2012 2026 2016 2021 451
  1. Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study (2012)
    John B. Buse, Michael A. Nauck et al. The Lancet

Immediate Impact

1 from Science/Nature 105 standout
Sub-graph 1 of 20

Citing Papers

Obesity in adults
2024 Standout
Medical, surgical, and physical treatments for Parkinson's disease
2024 Standout
4 intermediate papers

Works of Wayne H.-H. Sheu being referenced

Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study
2012 Standout

Author Peers

Author Last Decade Papers Cites
Wayne H.-H. Sheu 608 81 218 235 13 830
Somlak Chuengsamarn 304 117 114 239 16 906
Cíntia Rabelo e Paiva Caria 476 75 198 210 15 671
Helayne Soares Freitas 415 79 313 342 21 925
Tomomi Ishihara 359 72 227 358 13 709
Gian Piero Carnevale Schianca 496 145 152 249 26 828
Matthews Dr 751 88 252 306 14 971
Michelle J. Bound 544 64 257 210 23 914
Hiromi Fujishima 374 194 205 256 12 986
Shalini Jaggi 394 105 114 157 24 806
Roberto Mereu 295 117 158 170 33 669

All Works

Loading papers...

Rankless by CCL
2026